BioCentury | Aug 6, 2020
Management Tracks

Kindler joins Blackstone as senior adviser; plus changes at Mission, Annexon, Dyne, Ribometrix, Autolus and more

...Centrexion Therapeutics Corp. and served as chairman and CEO of Pfizer Inc. (NYSE:PFE) in 2006-10. Mission Therapeutics Ltd....
...Ltd. (NSE:GLENMARK; BSE:532296) and Sangamo Therapeutics Inc. (NASDAQ:SGMO). Robin Sawka, BioCentury Staff Blackstone Group Ribometrix Inc. Dyne Therapeutics Inc. Annexon Inc. Mission Therapeutics Ltd. Autolus...
BioCentury | Apr 24, 2020
Emerging Company Profile

FoRx: A broader look at DNA damage repair

...Inc. unit of Merck KGaA (Xetra:MRK) and CSO at Metabomed Ltd. Goddard is chairman of Mission Therapeutics Ltd....
BioCentury | Feb 10, 2020
Finance

Woodford pain continues as report suggests deal to sell private biotech stakes falls through

...plc (LSE:DDDD) $98.2 Inivata Ltd. $97.4 Carrick Therapeutics Ltd. $95.0 Northwest Biotherapeutics Inc. (OTCQB:NWBO) $95.0 Mission Therapeutics Ltd....
BioCentury | Oct 19, 2019
Finance

Woodford’s empire crumbles. U.K biotech stays standing

...plc (LSE:DDDD) $98.2 Inivata Ltd. $97.4 Carrick Therapeutics Ltd. $95.0 Northwest Biotherapeutics Inc. (OTCQB:NWBO) $95.0 Mission Therapeutics Ltd....
BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

...in orphan disease Musculoskeletal, endocrine/ metabolic, pulmonary, cancer Cardiorentis AG $118.3 1/11/16 Small molecules Cardiovascular Mission Therapeutics Ltd....
BioCentury | Apr 25, 2019
Emerging Company Profile

Cell Mogrify directly reprograms cells in vivo

...Cambridge’s Gurdon Institute. Jackson also co-founded cancer company KuDos Pharmaceuticals Ltd. and targeted degradation company Mission Therapeutics Ltd....
...Pharmaceuticals Ltd., Cambridge, U.K. Medical Research Council Laboratory of Molecular Biology (MRC LMB), Cambridge, U.K. Mission Therapeutics Ltd....
BioCentury | Apr 16, 2019
Preclinical News

Mounting a mitochondrial attack to starve the inflammasome

...induced mitophagy as a therapeutic approach beyond NLRP3 inflammasome activation. At least two companies -- Mission Therapeutics Ltd....
...pyrin domain containing 3; SLC44A1 (CTL1) - Solute carrier family 44 member 1 Allison Johnson, Staff Writer Mission Therapeutics Ltd. Novintum...
BioCentury | Nov 16, 2018
Company News

AbbVie strengthens early stage neurology focus with Mission deal

...Pipeline From BioArtic" ). Mission Therapeutics Ltd., Cambridge, U.K. AbbVie Inc. (NYSE:ABBV), Chicago, Ill. Business: Neurology Allison Johnson AbbVie Inc. Mission Therapeutics Ltd. deubiquitinase DUB...
BioCentury | Sep 20, 2018
Distillery Therapeutics

Cancer

...Inc. has the small molecule USP7 inhibitor P5091 in preclinical testing for multiple myeloma (MM). Mission Therapeutics Ltd....
BioCentury | Sep 7, 2018
Financial News

Winter, Jackson, Ramakishnan, Balasubramaniam among co-founders of new U.K. fund Ahren

...U.K.) (see “Bicycle Therapeutics: Peddling Peptides” ). Jackson founded cancer companies KuDOS Pharmaceuticals Ltd. and Mission Therapeutics Ltd....
Items per page:
1 - 10 of 38
BioCentury | Aug 6, 2020
Management Tracks

Kindler joins Blackstone as senior adviser; plus changes at Mission, Annexon, Dyne, Ribometrix, Autolus and more

...Centrexion Therapeutics Corp. and served as chairman and CEO of Pfizer Inc. (NYSE:PFE) in 2006-10. Mission Therapeutics Ltd....
...Ltd. (NSE:GLENMARK; BSE:532296) and Sangamo Therapeutics Inc. (NASDAQ:SGMO). Robin Sawka, BioCentury Staff Blackstone Group Ribometrix Inc. Dyne Therapeutics Inc. Annexon Inc. Mission Therapeutics Ltd. Autolus...
BioCentury | Apr 24, 2020
Emerging Company Profile

FoRx: A broader look at DNA damage repair

...Inc. unit of Merck KGaA (Xetra:MRK) and CSO at Metabomed Ltd. Goddard is chairman of Mission Therapeutics Ltd....
BioCentury | Feb 10, 2020
Finance

Woodford pain continues as report suggests deal to sell private biotech stakes falls through

...plc (LSE:DDDD) $98.2 Inivata Ltd. $97.4 Carrick Therapeutics Ltd. $95.0 Northwest Biotherapeutics Inc. (OTCQB:NWBO) $95.0 Mission Therapeutics Ltd....
BioCentury | Oct 19, 2019
Finance

Woodford’s empire crumbles. U.K biotech stays standing

...plc (LSE:DDDD) $98.2 Inivata Ltd. $97.4 Carrick Therapeutics Ltd. $95.0 Northwest Biotherapeutics Inc. (OTCQB:NWBO) $95.0 Mission Therapeutics Ltd....
BioCentury | May 24, 2019
Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

...in orphan disease Musculoskeletal, endocrine/ metabolic, pulmonary, cancer Cardiorentis AG $118.3 1/11/16 Small molecules Cardiovascular Mission Therapeutics Ltd....
BioCentury | Apr 25, 2019
Emerging Company Profile

Cell Mogrify directly reprograms cells in vivo

...Cambridge’s Gurdon Institute. Jackson also co-founded cancer company KuDos Pharmaceuticals Ltd. and targeted degradation company Mission Therapeutics Ltd....
...Pharmaceuticals Ltd., Cambridge, U.K. Medical Research Council Laboratory of Molecular Biology (MRC LMB), Cambridge, U.K. Mission Therapeutics Ltd....
BioCentury | Apr 16, 2019
Preclinical News

Mounting a mitochondrial attack to starve the inflammasome

...induced mitophagy as a therapeutic approach beyond NLRP3 inflammasome activation. At least two companies -- Mission Therapeutics Ltd....
...pyrin domain containing 3; SLC44A1 (CTL1) - Solute carrier family 44 member 1 Allison Johnson, Staff Writer Mission Therapeutics Ltd. Novintum...
BioCentury | Nov 16, 2018
Company News

AbbVie strengthens early stage neurology focus with Mission deal

...Pipeline From BioArtic" ). Mission Therapeutics Ltd., Cambridge, U.K. AbbVie Inc. (NYSE:ABBV), Chicago, Ill. Business: Neurology Allison Johnson AbbVie Inc. Mission Therapeutics Ltd. deubiquitinase DUB...
BioCentury | Sep 20, 2018
Distillery Therapeutics

Cancer

...Inc. has the small molecule USP7 inhibitor P5091 in preclinical testing for multiple myeloma (MM). Mission Therapeutics Ltd....
BioCentury | Sep 7, 2018
Financial News

Winter, Jackson, Ramakishnan, Balasubramaniam among co-founders of new U.K. fund Ahren

...U.K.) (see “Bicycle Therapeutics: Peddling Peptides” ). Jackson founded cancer companies KuDOS Pharmaceuticals Ltd. and Mission Therapeutics Ltd....
Items per page:
1 - 10 of 38